0001427925-11-000001.txt : 20110713 0001427925-11-000001.hdr.sgml : 20110713 20110713115345 ACCESSION NUMBER: 0001427925-11-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110713 DATE AS OF CHANGE: 20110713 EFFECTIVENESS DATE: 20110713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-162776 FILM NUMBER: 11965238 BUSINESS ADDRESS: STREET 1: 575 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 575 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 D 1 primary_doc.xml X0704 D LIVE 0001427925 ACELRX PHARMACEUTICALS INC 575 CHESAPEAKE DRIVE REDWOOD CITY CA CALIFORNIA 94063 650-216-3500 DELAWARE SURX, INC. None Corporation true Richard King c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Executive Officer Director Pamela P. Palmer c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Executive Officer Hamel G. Lawrence c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Executive Officer Badri N. Dasu c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Executive Officer James H. Welch c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Executive Officer Thomas Schreck c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Director Stephen J. Hoffman c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Director Guy Nohra c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Director Howard B. Rosen c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Director Mark Wan c/o AcelRx Pharmaceuticals, Inc. 575 Cheasapeake Drive Redwood City CA CALIFORNIA 94063 Director Biotechnology Decline to Disclose 06 false 2011-06-29 false true true true false 0 20839994 20839994 0 Promissory Notes in which $3,000,000 dollars of which can be converted into Company Common Stock at a fixed conversion price of $5.73; Warrants to purchase Common Stock and Common Stock issuable upon exercise of Warrants and conversion of Promissory Notes false 2 0 0 0 Proceeds will be used for the ARX-01 Phase 3 clinical trial in addition to the general business purposes. false ACELRX PHARMACEUTICALS INC /s/ James H. Welch James H. Welch Chief Financial Officer 2011-07-13